Searched for
PIRAMAL PHARMA EARNINGS
Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsFrom a macro perspective, it is clearly a good time to be bullish. But as valuations remain high in parts of the market despite the recent ...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 27% in 1 yearAfter the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...
- Q4 earnings roundup: Raymond Realty, MCX among 19 companies that delivered 100%+ growth in sales and PATA select group of 19 large-cap BSE-listed companies achieved triple-digit growth in both profit and revenue during Q4FY26, indicating stron...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Smallcaps rally! IIFL Finance, Hindustan Copper, Meesho, other stocks jump up to 7%Smallcap stocks, including IIFL Finance, Meesho, and GRSE, surged up to 7% on Wednesday, outperforming benchmark indices. This rally occurr...
- Smallcaps & midcaps rally! Firstsource Solutions, Nuvama, Godfrey Phillips, other stocks jump up to 16%Smallcap and midcap stocks outperformed benchmarks on Friday, with select names rallying up to 16% despite broader market weakness. Gains w...
- Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
- Vedanta demerger: When will the four new stocks list on NSE, BSE? Here's what investors can expectVedanta’s demerger has left investors awaiting the listing of its four newly carved-out entities, even as the parent stock continues to ris...
- Nandini Piramal warns prolonged West Asia war may raise input costsGeopolitical tensions in West Asia are manageable now. However, a prolonged US-Israel war against Iran could raise costs for petrochemical-...
- Piramal Pharma posts Rs 10 crore net profit in Q3FY24Piramal Pharma Q3 Results: Revenue from operations rose 14% YoY driven by double digit growth across all the three businesses.
- After a tough year, Piramal Pharma hopes to regain vigour in 2nd halfPiramal Pharma chairperson Nandini Piramal in an interview to ET said the company is aiming for mid-teen revenue growth and a meaningful im...
- Pickup in contract manufacturing biz set to drive growth: Piramal Pharma"During the year (FY23), the customer decision-making got delayed due to macro-economic environment and pipeline prioritisation based on li...
- Piramal Pharma Q4 Results: Net profit slides 75% YoY to Rs 50 croreOn like-to-like financials, the CDMO business that contributes 57% of revenues, declined 8% YoY to Rs 2164 crore. The complex hospital gene...
- Piramal Pharma Q3 Results: Firm reports Rs 90 cr loss, gets board nod to raise up to Rs 1,050 crPiramal Pharma said while the YoY financials are not strictly comparable due to the non-inclusion of certain "non-common control transactio...
- Piramal Pharma Q2 Results: Piramal Pharma post net loss of Rs 37 crore in Q2FY23The complex hospital generic business that contributes one-third of revenues grew 12% YoY to Rs 562 crore. Piramal said it is witnessing st...
- Piramal Enterprise gets board nod for demerger and listing of pharma businessThe pharmaceuticals business will get vertically demerged from Piramal Enterprises and consolidated under Piramal Pharma Ltd (PPL), the gro...
- Piramal Pharma completes acquisition of Hemmo PharmaceuticalsIn March this year, Piramal Pharma Ltd entered into an agreement to acquire a 100 per cent stake in Hemmo Pharmaceuticals for an upfront co...
- Piramal Pharma to acquire 100% stake in Hemmo Pharma for Rs 775 crConsequent to the acquisition, Hemmo Pharmaceuticals Pvt Ltd would become a wholly-owned subsidiary of Piramal Pharma Ltd (PPL).
- Piramal Healthcare: Acquisition of Decision Resources Group can boost company's valuationGiven Piramal's track record of successful mergers and acquisitions, investors will be banking on the company's latest buyout, DRG, adding ...
Load More
